Q4 2025 Core Laboratories Inc Earnings Call Transcript
Key Points
- Core Laboratories Inc (CLB) reported a 3% increase in fourth-quarter revenue compared to the previous quarter, driven by strong international demand for proprietary technologies.
- The Reservoir Description segment saw a 5% increase in revenue compared to Q3 2025, reflecting continued demand for rock and fluid analysis.
- Core Laboratories Inc (CLB) maintained strong operating margins in the Reservoir Description segment at 14%, expanding sequentially by 60 basis points.
- The company continued its commitment to shareholder returns, repurchasing over 363,000 shares in Q4 2025 and 1.2 million shares for the full year.
- Core Laboratories Inc (CLB) celebrated its 90th anniversary, highlighting its long-term success and asset-light business model, which continues to drive shareholder value.
- The U.S. land market was seasonally soft, impacting overall performance despite international demand.
- Production Enhancement segment operating margins decreased to 7% in Q4 2025 from 11% in Q3, partly due to a provision for a potentially uncollectible receivable in Asia Pacific.
- Product sales were down 6% from the previous quarter and 4% year-over-year, primarily due to lower completion activity in the U.S. onshore market.
- Geopolitical conflicts and evolving sanctions negatively impacted demand for laboratory services tied to crude oil assay, contributing to commodity price volatility.
- Tariffs on certain imported raw materials increased supply costs and affected margins, particularly in the Production Enhancement segment.
Good day, and welcome to the Core Laboratories fourth-quarter and fiscal year 2025 earnings webcast and call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Larry Bruno, Chairman and CEO. Please go ahead.
Thanks, Dave. Good morning in the Americas. Good afternoon in Europe, Africa, and the Middle East. And good evening in Asia-Pacific. We'd like to welcome all of our shareholders, analysts, and most importantly our employees to Core Laboratories' fourth-quarter 2025 earnings call.
This morning, I'm joined by Chris Hill, Core's Chief Financial Officer; and Gwen Gresham, Core's Senior Vice President and Head of Investor Relations.
The call will be divided into six segments. Gwen will start by making remarks regarding forward-looking statements. We'll then have some opening comments, including a high-level review of important factors in Core's Q4 performance. In addition,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
